RxDoctor Payments Data

Eliana Green

Physician Assistant · Quincy, FLNPI 1114312881

Payments from drug & device makers

$5,115in general payments, 2019–2025

Across 273 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$599
  • Boehringer Ingelheim$558
  • Pfizer$523
  • Sanofi-aventis U.S. LLC$404
  • AstraZeneca$333
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$5,115100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,115 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide41$43,803
OzempicSemaglutide38$42,895
XifaxanRifaximin11$41,689
JardianceEmpagliflozin34$35,700
EntrestoSacubitril/Valsartan16$22,740
JanuviaSitagliptin Phosphate11$19,248
EliquisApixaban21$18,842
Breztri AerosphereBudesonide/Glycopyr/Formoterol25$15,834
Janumet XrSitagliptin Phos/Metformin Hcl13$15,125
FarxigaDapagliflozin Propanediol20$13,077
TradjentaLinagliptin18$9,409
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$6,089
Omeprazole88$1,905
Atorvastatin Calcium168$1,753
Amlodipine Besylate147$1,251

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$558$45,10952 claims
Lilly USA, LLCMounjaro$599$43,80341 claims
Novo NordiskOzempic$1,202$42,89538 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$211$41,68911 claims
MerckJanuvia, Janumet Xr$76$34,37324 claims
AstraZenecaBreztri Aerosphere, Farxiga$333$28,91045 claims
NovartisEntresto$47$22,74016 claims
PfizerEliquis$523$18,84221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Quincy

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →